Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Payables (2016 - 2025)

Historic Payables for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to $2.0 million.

  • AC Immune's Payables rose 1977.9% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 1977.9%. This contributed to the annual value of $3.0 million for FY2024, which is 9983.97% down from last year.
  • As of Q3 2025, AC Immune's Payables stood at $2.0 million, which was up 1977.9% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Payables ranged from a high of $2.2 billion in Q4 2021 and a low of $349904.7 during Q2 2022
  • For the 5-year period, AC Immune's Payables averaged around $267.4 million, with its median value being $2.0 million (2025).
  • In the last 5 years, AC Immune's Payables crashed by 9995.56% in 2022 and then skyrocketed by 19618586.97% in 2023.
  • Over the past 5 years, AC Immune's Payables (Quarter) stood at $2.2 billion in 2021, then plummeted by 99.96% to $964322.2 in 2022, then surged by 196185.87% to $1.9 billion in 2023, then crashed by 99.84% to $3.0 million in 2024, then crashed by 35.48% to $2.0 million in 2025.
  • Its Payables stands at $2.0 million for Q3 2025, versus $3.3 million for Q2 2025 and $2.7 million for Q1 2025.